News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, January 6, 2020

PRESBYTERIAN HEALTH FOUNDATION GRANT PROGRAMS – CALL FOR PROPOSALS ANNOUNCEMENT

The Presbyterian Health Foundation will fund $3.85 million in grants for 2020.  Provided below is information on grant type

and application due date. Guidelines with application and additional information will be available in the upcoming week

Grant Type

Due Date

Bridge

April 17, 2020

Seed

February 28, 2020

Team Science

February 28, 2020

Equipment

February 28, 2020

Symposium

February 28, 2020

Clinician Scientist Development

February 28, 2020

Research Support

February 28, 2020

New Investigator Seed

February 28, 2020

If you have any questions, please email ORA4PHF@ouhsc.edu.

 

 

OCAST DEADLINES – See Below

 

OK-INBRE Call for Mentors for the Summer Undergraduate Research Program

The OK-INBRE Summer Undergraduate Research Program exposes promising students to the exciting world of research and

acts as a mechanism for increasing the applicant pool for graduate programs in biomedical research at Oklahoma's comprehensive

campuses.  We are now seeking mentors for the summer of 2020.  Each selected student will receive a salary of $5,000

(subject to taxes) to pay for living expenses over the summer (May 26 - July 21, 2020). In addition, each Mentor's laboratory

will receive $2,200 for supplies. Each student will present a scientific poster of their summer research project at the end of the

program. The cost of preparing the poster is to be covered by the aforementioned $2,200 allocation for supplies.

If you are interested in serving as a faculty mentor, please complete the online application form located at

https://okinbre.ouhsc.edu/Undergraduate-Research/Summer-Faculty-Mentors by January 15th, 2020. Applications from

prospective faculty mentors at both the research-intensive institutions and Oklahoma regional universities are strongly encouraged. 

Applications from current and former COBRE Investigators at OUHSC and OMRF are also strongly encouraged. If you are

matched with a student, you will be contacted by the SURP Staff.

 

NCI calls your attention to a pair of published “Early K99/R00” Funding Opportunity Announcements, RFA-CA-20-014  and

RFA-CA-20-015  The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers.

An Informational Webinar is scheduled for Wednesday, January 8th, 2020, from 1 – 3 pm EST for potential applicants and their

mentors, business officials, and heads of graduate programs. All potential applicants from the Stephenson Cancer Center/

OUHSC/OU Norman should attend the webinar.   Letters of Intent are due January 26, 2020; applications are due

February 26, 2020. Please share the attached flier and Webinar Invitation.  

The NCI Early K99/R00 program is designed to suit the career paths of postdoctoral fellows pursuing careers in Data Science and

Cancer Control Science, who typically require only a short period of mentored research training beyond their doctoral degrees

before obtaining independent faculty positions. Postdoctoral fellows in other areas of NCI-supported research are encouraged to

apply to the NIH Parent K99/R00 program (PA-19-129 and PA-19-130 ).

The Early K99/R00 differs from the NIH Parent K99/R00 program in that:

  • Applicants may have no more than 2 years of postdoctoral research experience by the

application due date (February 26, 2020);

  • A nomination letter is required;
  • Preliminary data are NOT required; and
  • Institutions may submit a combined total of up to three applications per due date, inclusive of both RFAs: one for Data
  • Science, one for Cancer Control Science, and/or one for “Other Sciences” as defined in Section III, Part 3 of the RFAs.
  • An application should be submitted to the appropriate RFA (Clinical Trials Required or Clinical Trials Not Allowed).

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-014.html

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-015.html

https://research.ouhsc.edu/Portals/1329/Assets/Documents/earlyK99_2020_Webinar_Invitation.docx?ver=2020-01-02-072907-520

https://research.ouhsc.edu/Portals/1329/Assets/Documents/earlyK99_flier_2020.pdf?ver=2020-01-02-072907-520

 

ORIP is participating in NOT-AG-20-008, “Alzheimer’s-focused administrative supplements for NIH grants that

are not focused on Alzheimer’s disease.”  ORIP and other participating Institutes, Centers and Offices are invitingapplications

to expand existing awards that are not currently focused on Alzheimer’s disease and its related dementias (ADRD) to allow them to

develop a focus on ADRD.  Requests must be received on March 6, 2020 by 5 pm local time of the applicant organization for funding

in FY 2020.  For additional information please see the attached document.  https://research.ouhsc.edu/Portals/1329/Assets/Documents/ORIP_Alzheimers.docx?ver=2019-12-09-074004-407

https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-008.html

 

 

NIH NOTICES

 

NIH Operates Under a Continuing Resolution (NOT-OD-20-046)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-046.html

 

Notification of HHS Plan to Publish a Statement Announcing the Intention to Convene an NIH Human Fetal Tissue Research Ethics

Advisory Board for Fiscal Year 2020 and Soliciting Nominations
(NOT-OD-20-053)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-053.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for the Laboratory Flexible Funding Model (LFFM) (U18) Clinical

Trial Not Allowed (NOT-FD-20-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-FD-20-004.html

 

NHLBI Division of Blood Diseases and Resources Announces Contact Information for Potential Training and/or Career Development

Award Applicants (NOT-HL-19-730)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-730.html

 

Notice of Frequently Asked Questions for RFA-HL-20-014 "Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders

(UG3/UH3 Clinical Trial Not Allowed)" (NOT-HL-19-736)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-736.html

 

Announcing the Interagency Collaborative Animal Research Education (ICARE) 2020 Workshop Schedule and Open Registration

(NOT-OD-20-045)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-045.html

 

Learning from the Transfer of HIV Interventions from Low- and Middle-Income Countries (LMICs) to the United States: Informing the

Plan for America to End the HIV Epidemic (NOT-TW-19-008)

https://grants.nih.gov/grants/guide/notice-files/NOT-TW-19-008.html

Special Emphasis Notice (SEN): Health Services Research Priorities for Improving Diagnostic Safety and Quality (NOT-HS-20-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-20-004.html

 

Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for the 4D Nucleome Phase 2 RFAs (NOT-RM-20-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-RM-20-008.html

 

Notice of Participation of the National Institute on Aging (NIA) in PA-18-705 "SBIR Technology Transfer (R43/R44 Clinical Trial Not

Allowed)" (NOT-AG-20-010)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-010.html

 

Notice of Clarification of Funding Restriction Information in RFA-AI-19-068, Immune Tolerance Network (Clinical Trial Required UM1)

(NOT-AI-20-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-018.html

 

Notice of Change to PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"

(NOT-DA-20-028)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-028.html

 

Notice to Extend the Expiration Date of PAR-18-291: Transition to Independent Environmental Health Research (TIEHR) Career

Award (K01 Clinical Trial Not Allowed) (NOT-ES-20-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-ES-20-006.html

 

Notice to Extend the Expiration Date of PAR-18-261: Transition to Independent Environmental Health Research (TIEHR) Career

Award (K01 Clinical Trial Required) (NOT-ES-20-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-ES-20-008.html

 

Notice of Correction to application submission information for NOT-HL-19-724 "Notice of Special Interest (NOSI): Availability of

Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI" (NOT-HL-19-740)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-740.html

 

Notice of NHLBI Participation in PAR-19-307, "Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected

Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)" (NOT-HL-19-745)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-745.html

 

Notice of NLM Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC)

Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)" (NOT-LM-20-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-LM-20-002.html

 

Notice to Extend the Expiration Date for PA-18-141 "Mechanisms, Models, Measurement, & Management in Pain Research

(R01 Clinical Trial Optional)" (NOT-NS-20-021)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-021.html

 

Notice to Extend the Expiration Date for PA-18-159 "Mechanisms, Models, Measurement, & Management in Pain Research

(R21 Clinical Trial Optional)" (NOT-NS-20-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-022.html

 

Notice of correction to PA-18-817 "Administrative Supplements for Research on Dietary Supplements"
(NOT-OD-20-052)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-052.html

 

Notice of Change to Award Budget and Removal of Prior Approval Requirement for PAR-19-099, Limited Competition: Clinical and

Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional) (NOT-TR-20-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-004.html

 

Notice of Cancellation of PAR-17-315 "Pre-application for a Biomedical Technology Research Resource (X02)" (NOT-GM-20-010)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-010.html

 

Notice to Extend the Response Date for NOT-MH-20-003 " Request for Information (RFI) on the 2020 National Institute of Mental

Health (NIMH) Strategic Plan for Research" (NOT-MH-20-021)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-20-021.html

 

Notice of NINR's Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research

(Admin Supp Clinical Trial Not Allowed) (NOT-NR-20-001)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-20-001.html

 

Notice Revising Receipt Dates for PAR-15-352: Occupational Safety and Health Training Project Grants (T03) (NOT-OH-20-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-OH-20-003.html

 

Notice Revising Receipt Dates for PAR-15-303: Occupational Safety and Health Education and Research Centers (T42)

(NOT-OH-20-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-OH-20-004.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Biomedical Technology Development and Dissemination

Center (RM1 - Clinical Trial Not Allowed) (NOT-GM-20-011)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-011.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Pain Management Effectiveness Research

Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) (NOT-NS-20-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-020.html

 

Broad Agency Announcement (BAA): NHP MHC and KIR Allele Discovery and Typing Technology Development,

BAA-NIAID-DAIT-75N93019R00020 (NOT-AI-20-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-022.html

 

Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics (NOT-AI-20-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-013.html

 

Notice of Special Interest (NOSI): Development of Nucleic Acid-based Vaccines Against Seasonal and/or Pandemic Influenza

(NOT-AI-20-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-017.html

 

Notice of Special Interest: Administrative Supplements to Cancer Center Support Grants to Support Collaborations with the

Experimental Therapeutics Clinical Trials Network (ETCTN) through the Early Drug Development Opportunity Program (EDDOP)

(NOT-CA-20-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-017.html

 

Notice of Special Interest: Alzheimer’s-focused Administrative Supplements for NIH/NCI Grants that are not focused on

Alzheimer’s Disease (NOT-CA-20-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-019.html

 

Notice of Special Interest (NOSI): Addressing Health Disparities in NIDDK Diseases (NOT-DK-20-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-20-003.html

 

Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging
(NOT-EB-19-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-EB-19-022.html

 

Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated

with Heart, Lung, Blood, or Sleep Disease (NOT-HL-19-731)

https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-731.html

 

Notice of Special Interest (NOSI): Development of Animal Models of Down Syndrome and Related Biological Materials as

Part of the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project

(NOT-OD-20-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-017.html

 

Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2 Institutional Career

Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand

Down syndrome) Project (NOT-OD-20-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-022.html

 

Notice of Special Interest (NOSI): Competitive Supplements/Revisions (R01) Available for INCLUDE (Investigation of

Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision

Clinical Trial Optional) (NOT-OD-20-023)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-023.html

 

Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of

Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
(NOT-OD-20-024)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-024.html

 

Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE

(INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (NOT-OD-20-025)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-025.html

 

Notice of Special Interest (NOSI): Availability of Administrative Supplements to Accelerate Dissemination of Emerging

Glycoscience Tools through Collaborations Between Developers and Early Adopters
(NOT-RM-20-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-RM-20-003.html

 

 
Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least two months prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not

Allowed) (PAR-20-078) – Deadline February 26, 2020 and October 28, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-20-078.html

 

Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed)

(RFA-AG-21-002) – Deadline June 17, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-002.html

 

Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) (RFA-AG-21-010) – Deadline June 17, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-010.html

Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) (RFA-AI-19-072)
Deadline April 1, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-072.html

 

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research

(R01 Clinical Trial Optional) (RFA-CA-20-021) – Deadline February 21, 2020 and May 28, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-021.html

 

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research

(U01 Clinical Trial Optional) (RFA-CA-20-022) – Deadline February 21, 2020 and May 28, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-022.html

 

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research

(U54 Clinical Trial Optional) (RFA-CA-20-023) - Deadline February 21, 2020 and May 28, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-023.html

 

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research

(P01 Clinical Trial Optional) (RFA-CA-20-024) – Deadline February 21, 2020 and May 28, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-024.html

 

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research

(P50 Clinical Trial Optional) (RFA-CA-20-025) - Deadline February 21, 2020 and May 28, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-025.html

 

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research

(U2C Clinical Trial Optional) (RFA-CA-20-026) – Deadline February 21, 2020 and May 28, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-026.html

 

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation to Human from Rabbit for

Ophthalmic Drug Products (U01) Clinical Trials Not Allowed (RFA-FD-20-018) – Deadline February 27, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-20-018.html

 

Bioequivalence of Topical Products: Elucidating Fundamental Principles of Dermal Pharmacokinetics for

Microdialysis or Microperfusion Techniques (U01) Clinical Trials Not Allowed (RFA-FD-20-019) - Deadline

February 27, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-20-019.html

 

Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed))
(RFA-HD-21-013) - Deadline March 31, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-21-013.html

 

Improving Management of Opioids and Opioid Use Disorder (OUD) in Older Adults (R18)
(RFA-HS-20-001) - Deadline February 20, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-HS-20-001.html

 

Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV

In the Central Nervous System (CNS) (R01 Clinical Trial Optional) (RFA-MH-20-330)
Deadline March 11, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-330.html

 

Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV

In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed) (RFA-MH-20-331)
Deadline March 11, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-331.html

 

Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) (RFA-RM-20-007)
Deadline March 17, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-007.html

 

Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed)
(RFA-RM-20-008) - Deadline March 17, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-008.html

 

Transferring Harmonized Laboratory Data from Healthcare Institutions to Registries Using FHIR Protocol

(U01) Clinical Trials Not Allowed (RFA-FD-20-017) – Deadline March 4, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-20-017.html

 

Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations

(R21- Clinical Trials Not Allowed) (RFA-MD-20-005) – Deadline March 13, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-20-005.html

 

 

OTHER DEADLINES

 

Oklahoma Center for the Advancement of Science and Technology (OCAST) – Oklahoma Health Research

Deadline March 2, 2020 NO LATER THAN 5:00pm

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/Pro-Health.html

 

OCAST – Health Research Postdoctoral Fellowship – Deadline March 2, 2020 NO LATER THAN 5:00pm

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/PROGRAMS/index.html

 

OCAST – Oklahoma Applied Research Support - Deadline March 2, 2020 NO LATER THAN 5:00pm

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/Pro-OARS.html

 

OCAST – Faculty and Student Intern Partnerships - Deadline March 2, 2020 NO LATER THAN 5:00pm

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/Pro-Intern.html

 

OCAST – Basic Plant Science - Deadline March 2, 2020 NO LATER THAN 5:00pm

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/Pro-Plant.html

Print